New York S 5580: Requires that a member of the Westchester county industrial development agency is a member of the governing body of Westchester county

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S05580 Summary:

BILL NOS05580 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORLANZA

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Rpld §206 sub 1 ¶(o), add §280-d, Pub Health L; amd §§6810 & 6816-a, Ed L

&nbsp

Requires the commissioner of health to establish and publish a list of generic drug products.

Go to top S05580 Actions:

BILL NOS05580 

&nbsp

02/25/2025REFERRED TO HEALTH

01/07/2026REFERRED TO HEALTH

Go to topS05580 Committee&nbspVotes:

Go to topS05580 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS05580 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 5580

 2025-2026 Regular Sessions

 IN SENATE

 February 25, 2025
 ___________

 Introduced by Sen. LANZA -- read twice and ordered printed, and when
 printed to be committed to the Committee on Health

 AN ACT to amend the public health law and the education law, in relation
 to generic drug products; and to repeal paragraph (o) of subdivision 1
 of section 206 of the public health law relating thereto

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Paragraph (o) of subdivision 1 of section 206 of the public
 2 health law is REPEALED.
 3 § 2. The public health law is amended by adding a new section 280-d to
 4 read as follows:
 5 § 280-d. Generic drug products. 1. The commissioner shall establish
 6 and publish a list of drug products, referred to in this section as
 7 "generic drug" products, each of which shall meet the following condi-
 8 tions:
 9 (a) The drug product has been certified or approved by the commission-
 10 er of the Federal Food and Drug Administration as being safe and effec-
 11 tive for its labeled indications for use, and a new-drug application or
 12 an abbreviated new-drug application approved pursuant to the Federal
 13 Food, Drug, and Cosmetic Act is held for such drug product; and
 14 (b) The commissioner of the Federal Food and Drug Administration has
 15 evaluated such drug product as: (i) pharmaceutically and therapeutically
 16 equivalent and has listed such drug product on the list of approved drug
 17 products with the therapeutic equivalence evaluations, provided, howev-
 18 er, that the list prepared by the commissioner shall not include any
 19 drug product which the commissioner of the Federal Food and Drug Admin-
 20 istration has identified as having an actual or potential bioequivalence
 21 problem or (ii) as an interchangeable biological product and has listed
 22 such product on the list of approved drug products with interchangeabil-
 23 ity.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD09660-01-5

 S. 5580 2

 1 2. The manufacturer of a generic drug product shall make available to
 2 the department the studies and summaries, including bioequivalence data,
 3 therapeutic equivalence data, and incidence of adverse events, and asso-
 4 ciated analytical methods, including dissolution data and test methods
 5 provided to the Federal Food and Drug Administration as part of the
 6 application for such generic drug product. The department shall make
 7 such information freely and publicly available on its website.
 8 § 3. Paragraphs (a) and (e) of subdivision 6 of section 6810 of the
 9 education law, paragraph (a) as amended by chapter 590 of the laws of
 10 2011 and paragraph (e) as amended by chapter 357 of the laws of 2017,
 11 are amended to read as follows:
 12 (a) Every prescription written in this state by a person authorized to
 13 issue such prescription shall be on prescription forms containing one
 14 line for the prescriber's signature. The prescriber's signature shall
 15 validate the prescription. Every electronic prescription shall provide
 16 for the prescriber's electronic signature, which shall validate the
 17 electronic prescription. Imprinted conspicuously on every prescription
 18 written in this state in eight point upper case type immediately below
 19 the signature line shall be the words: "THIS PRESCRIPTION WILL BE FILLED
 20 GENERICALLY UNLESS PRESCRIBER WRITES 'd a w' IN THE BOX BELOW". Unless
 21 the prescriber writes d a w in such box in the prescriber's own hand-
 22 writing or, in the case o